4.3 Article

Psychiatric comorbidities in patients suffering from systemic lupus erythematosus admitted to a tertiary care hospital in Northern India

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Systematic Review of Psychiatric Adverse Effects Induced by Chloroquine and Hydroxychloroquine: Case Reports and Population Studies

Fernanda Talarico et al.

Summary: This article provides a systematic review of the psychiatric adverse effects of chloroquine and hydroxychloroquine, comparing clinical trials, populational studies, and case report studies. The current literature suggests that both drugs carry a risk of short-term psychiatric adverse effects.

ANNALS OF PHARMACOTHERAPY (2023)

Article Psychiatry

A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus

Jiafen Liao et al.

Summary: There is a positive correlation between the disease activity of systemic lupus erythematosus (SLE) and the severity of depression and anxiety. Patients with SLEDAI scores greater than 8.5 are more likely to suffer from mental disorders that require additional attention.

BMC PSYCHIATRY (2022)

Review Medicine, General & Internal

Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management

Lou Kawka et al.

Summary: Fatigue is a common symptom in patients with SLE, affecting 67% to 90% of patients. It can impair health-related quality of life and lead to employment disability. Management should include targeted interventions such as pharmacological treatments and non-pharmacological therapies like psychological interventions and lifestyle changes.

JOURNAL OF CLINICAL MEDICINE (2021)

Meeting Abstract Biochemistry & Molecular Biology

Prevalence of Neuropsychiatric Disorders in Patients With Systemic Lupus Erythematosus (SLE)

Anurag Punnam et al.

FASEB JOURNAL (2020)

Review Medicine, General & Internal

Glucocorticoids inSystemic Lupus Erythematosus. Ten Questions and Some Issues

Sabrina Porta et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Medicine, General & Internal

Hydroxychloroquine: A multifaceted treatment in lupus

Nathalie Costedoat-Chalumeau et al.

PRESSE MEDICALE (2014)

Article Medicine, General & Internal

Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis

Laura Manea et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)

Article Health Care Sciences & Services

Psychosocial dimensions of SLE: implications for the health care team

Nancy L. Beckerman et al.

JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2011)

Article Rheumatology

Prevalence of Mood and Anxiety Disorders in Women With Systemic Lupus Erythematosus

Elizabeth A. Bachen et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)

Review Medicine, General & Internal

Psychiatric adverse effects of corticosteroids

Thomas P. Warrington et al.

MAYO CLINIC PROCEEDINGS (2006)

Article Medicine, General & Internal

A brief measure for assessing generalized anxiety disorder -: The GAD-7

Robert L. Spitzer et al.

ARCHIVES OF INTERNAL MEDICINE (2006)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Article Health Care Sciences & Services

The PHQ-9 - Validity of a brief depression severity measure

K Kroenke et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2001)